Showing results (321-330 of 3,148) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|November 23, 2019
A pilot randomized controlled trial of exercise to improve cognitive performance in patients with stable glioma: a proof of conceptKarin Gehring, Martijn M Stuiver, Eva Visser, et al.
Neuro-Oncology|November 21, 2019
INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastomaMartin Van Den Bent, Marica Eoli, Juan Manuel Sepulveda, et al.
Neuro-Oncology|February 13, 2019
Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensusDavid Schiff, Martin Van den Bent, Michael A Vogelbaum, et al.
Neuro-Oncology|February 13, 2019
The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patientsLin Yu, Jinling Xu, Jing Liu, et al.
Neuro-Oncology|July 17, 2021
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapseStacey Richardson, Rebecca M Hill, Christopher Kui, et al.
Neuro-Oncology|July 24, 2021
SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncologyUgonma N Chukwueke, Elizabeth Vera, Alvina Acquaye, et al.
Neuro-Oncology|July 13, 2021
Characterization of systemic immunosuppression by IDH mutant glioma small extracellular vesiclesNils Ludwig, Aparna Rao, Poorva Sandlesh, et al.
Neuro-Oncology|December 15, 2020
Tumor cell network integration in glioma represents a stemness featureRuifan Xie, Tobias Kessler, Julia Grosch, et al.
Neuro-Oncology|December 15, 2020
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell deliveryDalia Haydar, Haley Houke, Jason Chiang, et al.
Neuro-Oncology|December 21, 2020
High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study groupThomas Perwein, Martin Benesch, Daniela Kandels, et al.
Pageof 315